Quest Diagnostics PEG Ratio

The latest PEG ratio for DGX is 93.25. That is above the Healthcare sector average of -5.81. Investors often review this figure alongside Quest Diagnostics's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, DGX currently prints 93.25 for PEG ratio, while the sector average sits near -5.81. That is roughly 1705.2% above the sector mean. Large gaps often invite a closer look at Quest Diagnostics's growth, margins, and balance sheet.

A PEG ratio of 93.25 for Quest Diagnostics is not 'good' or 'bad' on its own. Compare it with the peer average (-5.81) and with DGX's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting DGX's PEG ratio (93.25), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Quest Diagnostics's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.